- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04516330
Can MicroRNA's Predict Multicentricity in Breast Cancer?
August 14, 2020 updated by: Yeliz Emine Ersoy, Bezmialem Vakif University
The aim of this study is to determine if microRNA's have role in predicting multicentricity in breast cancer.
If a specific microRNA will be found to be related with multicentricity, it will help us to make appropriate decisions on the treatment of patients with multicentric breast cancer.
Study Overview
Detailed Description
In the study that will be held at Bezmialem Vakif University Medical Faculty, General Surgery Department, 20 unifocal and 20 multifocal breast cancer patients will be included.
Tissues will be taken from both tumoral and normal breast tissues and they will be saved in microRNA later solution under -80°C.
Then, 84 microRNA's will be studied in these tissues to see if they express any of these microRNA's.
Study Type
Interventional
Enrollment (Actual)
57
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Istanbul, Turkey, 34306
- Bezmialem Vakif University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years to 68 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Having breast cancer
- Having no other malignancy
- Female patient
Exclusion Criteria:
- Having other malignancy
- Under 18 years old
- Male patient
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: unifocal breast cancer
patients having unifocal breast cancer
|
miRNA's expressed in breast cancer
|
Active Comparator: multicentric breast cancer
patients having multicentric breast cancer
|
miRNA's expressed in breast cancer
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
MicroRNA's in multicentric breast cancer
Time Frame: April 2014
|
Evaluation of 84 microRNA's in patients with multicentric breast cancer
|
April 2014
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Treatment plan according to the detected microRNA in patients with multicentric breast cancer
Time Frame: April 2014
|
If a specific microRNA will be detected in patients with multicentric breast cancer, treatment plan will be individualized according to the detected microRNA
|
April 2014
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
February 1, 2014
Primary Completion (Actual)
February 1, 2016
Study Completion (Actual)
April 1, 2019
Study Registration Dates
First Submitted
December 10, 2013
First Submitted That Met QC Criteria
August 14, 2020
First Posted (Actual)
August 18, 2020
Study Record Updates
Last Update Posted (Actual)
August 18, 2020
Last Update Submitted That Met QC Criteria
August 14, 2020
Last Verified
August 1, 2020
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- MCBC-MIR
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Multicentric Breast Cancer
-
EusaPharma (UK) LimitedTerminatedIdiopathic Multicentric Castleman's DiseaseUnited States
-
Northwestern UniversityNational Cancer Institute (NCI)RecruitingAnatomic Stage 0 Breast Cancer AJCC v8 | Prognostic Stage 0 Breast Cancer AJCC v8 | Breast Ductal Carcinoma In Situ | Invasive Breast Carcinoma | Multicentric Breast Carcinoma | Bilateral Breast CarcinomaUnited States
-
University of PennsylvaniaRecruitingCastleman Disease | Castleman's Disease, MulticentricUnited States
-
Peking Union Medical College HospitalUnknownMulticentric Castleman DiseaseChina
-
EusaPharma (UK) LimitedUniversity of Sheffield (ScHARR); KMC Health Care; Castleman Disease Collaborative...Not yet recruitingIdiopathic Multicentric Castleman's Disease
-
Beijing VDJBio Co., LTD.RecruitingIdiopathic Multicentric Castleman's DiseaseChina
-
Peking Union Medical College HospitalRecruitingZanuburutinib in Relapsed and Refractory iMCD: a Prospective, Single-center, Single-arm Trial (iMCD)Idiopathic Multicentric Castleman's DiseaseChina
-
Peking Union Medical College HospitalRecruitingIdiopathic Multicentric Castleman's DiseaseChina
-
UNC Lineberger Comprehensive Cancer CenterFogarty International Center of the National Institute of HealthRecruitingMulticentric Castleman DiseaseMalawi
-
National Cancer Institute (NCI)Active, not recruitingBreast Ductal Carcinoma In Situ | Invasive Breast Carcinoma | Multicentric Breast Carcinoma | Multifocal Breast Carcinoma | Synchronous Bilateral Breast CarcinomaUnited States, France, Spain, Canada, Saudi Arabia, Puerto Rico, Korea, Republic of, Ireland, Colombia, Mexico
Clinical Trials on miRNA
-
University of CataniaCompleted
-
University of GaziantepCompletedMultiple Sclerosis | Biomarker | miRNA | Epigenetic
-
Azienda Ospedaliera SS. Antonio e Biagio e Cesare...Recruiting
-
Université Catholique de LouvainRecruiting
-
Virginia Commonwealth UniversityOhio State UniversitySuspendedCerebrovascular DisordersUnited States
-
Royal Cornwall Hospitals TrustCompleted
-
Istituto Ortopedico RizzoliRecruitingAdolescent Idiopathic ScoliosisItaly
-
Sir Run Run Shaw HospitalNot yet recruiting
-
Phoenix Children's HospitalUnknownSystemic Inflammatory Response SyndromeUnited States
-
Fondazione Policlinico Universitario Agostino Gemelli...Completed